The board of directors of the Company approved removal of the noncompete clause for managers.

Published Date:2023-09-05

Original Link:https://www.onenessbio.com/en/news_detail242_2.htm

Statement
No	1	Date of announcement	2023/09/05	Time of announcement	16:12:38
Subject	The board of directors of the Company approved removal of the noncompete clause for managers.
To which item it meets	paragraph 21			Date of events	2023/09/05
Date of the board of directors resolution: 2023/09/05 Name and title of the managerial officer with permission to engage in competitive conduct: The Vice President,Cheng, Yung-Chie. Items of competitive conduct in which the officer is permitted to engage: The Head of IUSEA HEALTHCARE Co., Ltd. Period of permission to engage in the competitive conduct: For the duration of employment as a manager of the Company. Circumstances of the resolution (please describe the results of voting in accordance with Article 32 of the Company Act): The board of directors approved the proposal unanimously with no changes. If the permitted competitive conduct belongs to the operator of a mainland China enterprise, the name and title of the managerial officer (if it is not the operator of a mainland China enterprise, please enter “N/A” below): N/A Company name of the mainland China enterprise and the officer’s position in the enterprise: N/A Address of the mainland China enterprise: N/A Operations of the mainland China enterprise: N/A Impact on the company’s finance and business: N/A If the managerial officer or director has invested in the mainland China enterprise, the monetary amount of the investment and the officer or director’s shareholding ratio: N/A Any other matters that need to be specified: None.